Wider benefits of Ozempic, Wegovy put pressure on Canadian insurers to expand drug coverage

Shortly after Richard Neilson survived a heart attack and double bypass surgery in 2019, his cardiac surgeon invited him to join a clinical trial for a medication that researchers hoped would cut his risk for future heart attacks.The drug was semaglutide, now famous as Ozempic, the blockbuster Type 2 diabetes treatment that has become a medical and cultural phenomenon because of how readily it helps people lose weight.